PDCD1 and cancer: The PD-L1/PD-1 signaling axis mediates immune escape in the tumor microenvironment [68]; PD-L1 is selectively expressed on the surface of cancer cells, and its binding to PD-1 on the surface of activated T cells results in negative regulatory signal transmission, which decreases immune activity [72, 73].